154 related articles for article (PubMed ID: 24680442)
1. Potential benefit of transrectal saturation prostate biopsy as an initial biopsy strategy: decreased likelihood of finding significant cancer on future biopsy.
Li YH; Elshafei A; Li J; Hatem A; Zippe CD; Fareed K; Jones JS
Urology; 2014 Apr; 83(4):714-8. PubMed ID: 24680442
[TBL] [Abstract][Full Text] [Related]
2. Transrectal saturation technique may improve cancer detection as an initial prostate biopsy strategy in men with prostate-specific antigen <10 ng/ml.
Li YH; Elshafei A; Li J; Gong M; Susan L; Fareed K; Jones JS
Eur Urol; 2014 Jun; 65(6):1178-83. PubMed ID: 23768632
[TBL] [Abstract][Full Text] [Related]
3. Saturation prostate needle biopsy and prostate cancer detection at initial and repeat evaluation.
Pepe P; Aragona F
Urology; 2007 Dec; 70(6):1131-5. PubMed ID: 18158033
[TBL] [Abstract][Full Text] [Related]
4. When serial prostate biopsy is recommended: most cancers detected are clinically insignificant.
Zaytoun OM; Stephenson AJ; Fareed K; El-Shafei A; Gao T; Levy D; Jones JS
BJU Int; 2012 Oct; 110(7):987-92. PubMed ID: 22416859
[TBL] [Abstract][Full Text] [Related]
5. Is quantitative histologic examination useful to predict nonorgan-confined prostate cancer when saturation biopsy is performed?
Pepe P; Fraggetta F; Galia A; Grasso G; Piccolo S; Aragona F
Urology; 2008 Dec; 72(6):1198-202. PubMed ID: 19041023
[TBL] [Abstract][Full Text] [Related]
6. Prostate cancer detection at repeat biopsy: can pelvic phased-array multiparametric MRI replace saturation biopsy?
Pepe P; Garufi A; Priolo G; Candiano G; Pietropaolo F; Pennisi M; Fraggetta F; Aragona F
Anticancer Res; 2013 Mar; 33(3):1195-9. PubMed ID: 23482802
[TBL] [Abstract][Full Text] [Related]
7. Saturation technique does not decrease cancer detection during followup after initial prostate biopsy.
Lane BR; Zippe CD; Abouassaly R; Schoenfield L; Magi-Galluzzi C; Jones JS
J Urol; 2008 May; 179(5):1746-50; discussion 1750. PubMed ID: 18343412
[TBL] [Abstract][Full Text] [Related]
8. Office based transrectal saturation biopsy improves prostate cancer detection compared to extended biopsy in the repeat biopsy population.
Zaytoun OM; Moussa AS; Gao T; Fareed K; Jones JS
J Urol; 2011 Sep; 186(3):850-4. PubMed ID: 21788047
[TBL] [Abstract][Full Text] [Related]
9. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL?
Pepe P; Garufi A; Priolo G; Pennisi M
Clin Genitourin Cancer; 2015 Feb; 13(1):e27-30. PubMed ID: 25081324
[TBL] [Abstract][Full Text] [Related]
10. Does an inflammatory pattern at primary biopsy suggest a lower risk for prostate cancer at repeated saturation prostate biopsy?
Pepe P; Aragona F
Urol Int; 2011; 87(2):171-4. PubMed ID: 21778685
[TBL] [Abstract][Full Text] [Related]
11. PCA3 score accuracy in diagnosing prostate cancer at repeat biopsy: our experience in 177 patients.
Barbera M; Pepe P; Paola Q; Aragona F
Arch Ital Urol Androl; 2012 Dec; 84(4):227-9. PubMed ID: 23427750
[TBL] [Abstract][Full Text] [Related]
12. Low risk patients benefit from extreme anterior apical sampling on initial biopsy for prostate cancer diagnosis.
Elshafei A; Kartha G; Li Y; S Moussa A; Hatem A; Gao T; Jones JS
Prostate; 2014 Sep; 74(12):1183-8. PubMed ID: 24962004
[TBL] [Abstract][Full Text] [Related]
13. Prostate saturation biopsy following a first negative biopsy: state of the art.
Maccagnano C; Gallina A; Roscigno M; Raber M; Capitanio U; Saccà A; Pellucchi F; Suardi N; Abdollah F; Montorsi F; Rigatti P; Scattoni V
Urol Int; 2012; 89(2):126-35. PubMed ID: 22814003
[TBL] [Abstract][Full Text] [Related]
14. PCA3 score vs PSA free/total accuracy in prostate cancer diagnosis at repeat saturation biopsy.
Pepe P; Aragona F
Anticancer Res; 2011 Dec; 31(12):4445-9. PubMed ID: 22199313
[TBL] [Abstract][Full Text] [Related]
15. Multiparametric pelvic MRI accuracy in diagnosing clinically significant prostate cancer in the reevaluation of biopsy microfocal tumor.
Pepe P; Dibenedetto G; Garufi A; Priolo G; Pennisi M
Anticancer Res; 2015 Jan; 35(1):395-9. PubMed ID: 25550578
[TBL] [Abstract][Full Text] [Related]
16. Prostate cancer detection rate at repeat saturation biopsy: PCPT risk calculator versus PCA3 score versus case-finding protocol.
Pepe P; Aragona F
Can J Urol; 2013 Feb; 20(1):6620-4. PubMed ID: 23433132
[TBL] [Abstract][Full Text] [Related]
17. Detection rate for significant cancer at confirmatory biopsy in men enrolled in Active Surveillance protocol: 20 cores vs 30 cores vs MRI/TRUS fusion prostate biopsy.
Pepe P; Cimino S; Garufi A; Priolo G; Russo GI; Giardina R; Reale G; Barbera M; Panella P; Pennisi M; Morgia G
Arch Ital Urol Androl; 2016 Dec; 88(4):300-303. PubMed ID: 28073197
[TBL] [Abstract][Full Text] [Related]
18. Risk of repeat biopsy and prostate cancer detection after an initial extended negative biopsy: longitudinal follow-up from a prospective trial.
Ploussard G; Nicolaiew N; Marchand C; Terry S; Allory Y; Vacherot F; Abbou CC; Salomon L; de la Taille A
BJU Int; 2013 May; 111(6):988-96. PubMed ID: 23452046
[TBL] [Abstract][Full Text] [Related]
19. Prospective evaluation of an extended 21-core biopsy scheme as initial prostate cancer diagnostic strategy.
Ploussard G; Nicolaiew N; Marchand C; Terry S; Vacherot F; Vordos D; Allory Y; Abbou CC; Salomon L; de la Taille A
Eur Urol; 2014 Jan; 65(1):154-61. PubMed ID: 22698576
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy.
Roscigno M; Scattoni V; Freschi M; Abdollah F; Maccagnano C; Galosi A; Lacetera V; Montironi R; Muzzonigro G; Deho F; Deiana G; Belussi D; Chinaglia D; Montorsi F; Da Pozzo LF
BJU Int; 2012 May; 109(9):1329-34. PubMed ID: 21895935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
